Phospho-ERK1/ERK2 (T185/Y187) Antibody

About the Target

Phospho-ERK1/ERK2 (T185/Y187) is a target of interest in many antibody-based workflows. Phospho-ERK1/ERK2 (Thr185, Tyr187) refers to the activated forms of the extracellular signal-regulated kinases ERK1 and ERK2, which are ubiquitously expressed serine/threonine kinases in the Ras-Raf-MEK-ERK MAPK signaling cascade. ERK1 (379 aa) and ERK2 (360 aa) contain unique N- and C-terminal extensions and a kinase insert domain that confer signaling specificity. Depending on the literature source, Phospho-ERK1/ERK2 (T185/Y187) may also be discussed as Phospho-ERK1/ERK2 (T185/Y187) and ERK-1; ERK-2; erk1 erk2; ERK1b; ERT1; ERT2; Extracellular signal-regulated kinase 1; Extracellular signal-regulated kinase 2; extracellular signal-related kinase 1; extracellular-signal-regulated kinase 2; Insulin-stimulated MAP2 kinase; MAP kinase 1; MAP kinase 2; MAP kinase 3; MAP kinase isoform p42; MAP kinase isoform p44; MAPK 1; MAPK 2; MAPK 3.

Reported cellular context includes cell junction, cytoplasm, membrane, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following Phospho-ERK1/ERK2 (T185/Y187) across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.

Research Context

Phospho-ERK1/ERK2 (T185/Y187) is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell junction, cytoplasm, and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell junction, cytoplasm, and membrane across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• differences between total target abundance and site-specific regulation when modified forms are compared

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for Phospho-ERK1/ERK2 (T185/Y187). This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in Phospho-ERK1/ERK2 (T185/Y187) reflect biology rather than handling. When interpreting Phospho-ERK1/ERK2 (T185/Y187), it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep Phospho-ERK1/ERK2 (T185/Y187) trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.